Wordt geladen...
TMOD-02. IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA
Glioblastoma (GBM) is a very aggressive and invasive tumor that relapses within nine months of diagnosis and remains incurable despite advances in multimodal therapy including surgical resection, chemotherapy and radiation. Poor patient outcome has been linked to both marker expression of brain tumo...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692073/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1041 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|